Ruxolitinib vs Allogeneic SCT for Patients With Myelofibrosis According to Donor Availability
Clinical trial NCT03333187 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03333187
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-21
- Primary completion
- 2024-10-07
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.